Livestream

Antibiotic prescribing practices for UTIs in women within a large, academic health system

Thursday, October 5, 2023

11:10 AM – 11:14 AM US PST

Location: A105-106

Presenting Author(s)

Emily S. Johnson, MD (she/her/hers)

Fellow
National Capital Consortium
Baltimore, Maryland, United States

PDF

Co-Author(s)

KV

Kristin Voegtline, PhD

Assistant Professor
Johns Hopkins School of Medicine
Baltimore, Maryland, United States
SO

Sarah B. Olson, MPH

Sr. Research Data Manager
Johns Hopkins School of Medicine
Baltimore, Maryland, United States
ST

Susan Tuddenham, MD, MPH

Associate Professor, Infectious Diseases
Johns Hopkins
Baltimore, Maryland, United States
DP

Danielle Patterson, MD S.M.

Assistant Professor
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States

Disclosure(s):

Emily S. Johnson, MD: No financial relationships to disclose

Kristin Voegtline, PhD: No financial relationships to disclose

Sarah B. Olson, MPH: No financial relationships to disclose

Susan Tuddenham, MD, MPH: Hologic: Participate in research supported by donation of test kits to my institution (Ongoing)

Danielle Patterson, MD S.M.: No financial relationships to disclose

In this cross-sectional, retrospective analysis, antibiotic prescribing practices for women with UTI within a large, mid-Atlantic academic health system were compared to both health system and Infectious Disease Society of America (IDSA) guidelines. Of a total of 17,520 cases, patients most often received prescriptions for nitrofurantoin (39.4%), followed by trimethoprim-sulfamethoxazole (17.8%) and ciprofloxacin (14.7%). The overall compliance with health system or IDSA guidelines was 78.7%. Case characteristics predictive of increased guideline concordance were age less than 35 years, Black race, treatment in the Emergency Department and treatment by a midlevel provider. Future studies into reasons for guideline discordant prescribing are needed.